St. Jude Medical Portico Transcatheter Valve Demonstrates Promising Results in Feasibility Study
10:24 (15/11/11)Fuente: eleconomista.es St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced the feasibility study results for the company´s Portico TM Transcatheter Aortic Heart Valve, presented at the 23rd annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium...
Un estudio de viabilidad de la válvula aórtica percutánea Portico de St. Jude Medical muestra resultados prometedores